Literature DB >> 25031073

Psychotropic medication in geriatric psychiatric patients: use and unreported use in relation to serum concentrations.

Marit Tveito1, Jørgen G Bramness, Knut Engedal, Bernhard Lorentzen, Helge Refsum, Gudrun Høiseth.   

Abstract

PURPOSE: The aim of this observational study was to describe the type, number, and serum concentration levels of psychotropic drugs in elderly patients, on admission to a geriatric psychiatric inpatient unit. We further wanted to investigate the use and unreported use of psychotropic drugs by analyzing for a broad spectrum of drugs in the serum samples.
METHODS: A total of 236 patients were included. Drug use, patient characteristics, and diagnoses were recorded, and serum analysis was performed for a total of 56 psychotropic drugs in 233 of the patients.
RESULTS: Nine out of ten patients (88%) used one or more psychotropic drugs on admission to hospital; the mean use was 2.8 (95% confidence interval (CI) 2.6-2.9) drugs. In 25 patients (11%), drugs reported used were not detected in serum. Unreported use of drugs (serum analysis revealing one or more drugs not reported) was found in 100 patients (43%). This was more common in younger patients. Psychotropic polypharmacy (use of three or more psychotropic drugs) was found in 109 patients (47%). Patients with a main diagnosis of affective disorder used the most psychotropic drugs.
CONCLUSIONS: Psychotropic drugs are commonly used among geriatric psychiatric patients on admission to hospital. Psychotropic polypharmacy is a major concern among these patients. There was considerable unreported use of drugs within this population, and a low threshold for a broader serum analysis for psychotropic drugs appears indicated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25031073     DOI: 10.1007/s00228-014-1720-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  40 in total

1.  Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.

Authors:  Stephen Curran; Debbie Turner; Shabir Musa; John Wattis
Journal:  Int J Geriatr Psychiatry       Date:  2005-09       Impact factor: 3.485

2.  [Gender- and age-related differences in dosage and serum concentration of psychotropic drugs].

Authors:  Kjell Petter Bøgwald; Ida Rudberg; Lars Tanum; Helge Refsum
Journal:  Tidsskr Nor Laegeforen       Date:  2012-02-07

3.  Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004.

Authors:  Todd P Gilmer; Christian R Dolder; David P Folsom; William Mastin; Dilip V Jeste
Journal:  Psychiatr Serv       Date:  2007-07       Impact factor: 3.084

4.  To what extent does the indicator "concurrent use of three or more psychotropic drugs" capture use of potentially inappropriate psychotropics among the elderly?

Authors:  Eva Lesén; Max Petzold; Karolina Andersson; Anders Carlsten
Journal:  Eur J Clin Pharmacol       Date:  2009-02-12       Impact factor: 2.953

5.  Determinants of non-compliance and attrition in the elderly.

Authors:  D J Slymen; J A Drew; J P Elder; S J Williams
Journal:  Int J Epidemiol       Date:  1996-04       Impact factor: 7.196

6.  Drug compliance and unreported drugs in the elderly.

Authors:  A Spagnoli; G Ostino; A D Borga; R D'Ambrosio; P Maggiorotti; E Todisco; W Prattichizzo; L Pia; M Comelli
Journal:  J Am Geriatr Soc       Date:  1989-07       Impact factor: 5.562

Review 7.  A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity.

Authors:  Walid F Gellad; Jerry L Grenard; Zachary A Marcum
Journal:  Am J Geriatr Pharmacother       Date:  2011-02

8.  Drug therapy in the elderly: what doctors believe and patients actually do.

Authors:  I Barat; F Andreasen; E M Damsgaard
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

9.  Psychotropic drug use in the Norwegian general population in 2005: data from the Norwegian Prescription Database.

Authors:  Svein R Kjosavik; Sabine Ruths; Steinar Hunskaar
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-07       Impact factor: 2.890

10.  Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis.

Authors:  H S Lau; K S Beuning; E Postma-Lim; L Klein-Beernink; A de Boer; A J Porsius
Journal:  Pharm World Sci       Date:  1996-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.